Phase 2 Lymphoma Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with relapsed or refractory peripheral T-cell lymphoma (a type of blood cancer that has come back or stopped responding to treatment), confirmed by laboratory testing, with measurable tumours larger than 1.5cm — and whose disease meets at least one of these conditions: the tumour shrank by less than half after standard treatment; the cancer got worse after first- or second-line treatment; or new or growing tumours appeared after a stem cell transplant.
• People aged 18 or older.
• People with a general health and activity level that falls within an acceptable range for this trial (confirm with trial site).
• People whose major organ functions meet specific minimum thresholds, including blood counts, heart function, kidney function, liver function, and lung function (confirm with trial site for exact values).
• People who are able and willing to use reliable contraception from the time of joining the trial through to one year after the study ends.
• People with an estimated life expectancy of at least 3 months.
• People who are willing to sign a consent form agreeing to take part.

Who may not be able to join:

• People who had major surgery within the 4 weeks before starting treatment.
• People who have or have had another cancer, unless it has been fully treated with no active disease for at least 3 years, or unless it was a certain type of skin cancer, a benign tumour of the tonsils, or an early-stage cancer that was adequately treated.
• People who previously had an allogeneic stem cell transplant (using donor cells) that was not successful.
• People who have had a stroke or bleeding in the brain within the past 3 months.
• People with serious heart conditions — such as severe heart failure, a heart attack within the past 6 months, or uncontrolled irregular heartbeat — or significant lung disease.
• People with HIV infection, or currently active hepatitis B or hepatitis C.
• People with an infection that is not currently under control.
• People who are pregnant or breastfeeding.
• People with any other serious medical condition that the researchers believe could put the person at risk or interfere with how the study treatments work in the body.

Important: Always verify eligibility with the trial site directly before applying.